A new paradigm for the development of medicine

Pioneering AI for Clinical Trial Acceleration

A neural network that maps the landscape to specific pipelines and new opportunities

Neuroute

A new paradigm for the development of medicine

Pioneering AI for Clinical Trial Acceleration

A neural network that maps the landscape to specific pipelines and new opportunities

Neuroute

A new paradigm for the development of medicine

Pioneering AI
for Clinical Trial Acceleration

A neural network that maps the landscape to specific pipelines and new opportunities

Neuroute

Neuroute maps the association between every study, sponsor and site

Understand How the Landscape Relates to Your Pipeline

Turn intelligence into action for early stage portfolio decisions, clinical research & development and commercial planning & analysis.

Streamline Site Selection with Criteria-Based Performance

Assess all relevant sites that have conducted relevant studies based on historical performance. Model performance for your study and connect to ideal collaborators.

Model Enrollment Scenarios with Accuracy

Evaluate patient population, required subject numbers, study duration, competitive landscape, budget considerations, and potential markets. This analysis aids in refining site locations and study design for optimal outcomes.

Modus - Immunoglycan for Sepsis

Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.

Premium UX Template for Framer

Sites Analyzed

174

Studies Analyzed

7,010


Modus - Immunoglycan for Sepsis

Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.

Indications

8

Studies Analyzed

1,790

Psyrin - Serious mental illness

Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.

Premium UX Template for Framer

Patient Cohorts

12

Studies Analyzed

4,809

Psyrin - Serious mental illness

Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.

Indications

150%

Studies Analyzed

1,790

Li Ka Shing Institute of Health Sciences

Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.

Premium UX Template for Framer

Indications

21

Studies Analyzed

9,500

Li Ka Shing Institute of Health Sciences

Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.

Indications

8

Studies Analyzed

1,790

Use Memory to Power Programs

Review past successes and failures in the landscape and your pipeline. Discuss analyses across teams to build internal knowledge and reduce the risk of losing valuable information by collaborating effectively.

  • 01

    Patient Access

    Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics

  • Landscape Analysis

    Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.

    02

  • Site Selection

    Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing

    03

  • Model Enrollment

    Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.

    04

Use Memory to Power Programs

Review past successes and failures in the landscape and your pipeline. Discuss analyses across teams to build internal knowledge and reduce the risk of losing valuable information by collaborating effectively.

  • 01

    Patient Access

    Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics

  • Landscape Analysis

    Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.

    02

  • Site Selection

    Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing

    03

  • Model Enrollment

    Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.

    04

Use Memory to Power Programs

Review past successes and failures in the landscape and your pipeline. Discuss analyses across teams to build internal knowledge and reduce the risk of losing valuable information by collaborating effectively.

01

Patient Access

Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics

Site Selection

Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing

03

Landscape Analysis

Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.

02

Model Enrollment

Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.

04

The Science behind Neuroute

The Science behind Neuroute

A Model Based on the
Association Cortex of
The Human Brain

A Model Based on the Association Cortex of The Human Brain


The development and adoption of medicine is inherently complex. However, nature often holds solutions for such complexities, refined through time and evolution.


To enhance clinical development, we must evaluate and associate the criteria for successful studies with the identification of essential contributors and the impact on financial dynamics.


Neuroute is a model of the brain's association cortex for clinical development, effectively merging critical datasets to assist sponsors in reducing the cost of subsequent clinical studies.

"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."

Dr. Mike Emanuel // Former Head of Clinical Development

"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."

Dr. Mike Emanuel // Former Head of Clinical Development

"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."

Dr. Mike Emanuel // Former Head of Clinical Development

Correct the course of clinical development by
connecting critical information, in unlimited ways

Correct the course of clinical development by connecting critical information, in unlimited ways

Patient Population Analysis

Competitive Landscape

Country Selection

Indication Analysis

Literature Reviews

Protocol Development

Landscape Analysis

Site Selection

Feasibility

Study Design

Site Performance

Audits

Pipeline Review

In-License and Out-License Opportunities

Correct the course of clinical development by connecting critical information, in unlimited ways

Patient Population Analysis

Competitive Landscape

Country Selection

Indication Analysis

Literature Reviews

Protocol Development

Landscape Analysis

Site Selection

Feasibility

Study Design

Site Performance

Audits

Pipeline Review

In-License and Out-License Opportunities